India’s food regulator, the Food Safety and Standards Authority of India (FSSAI), issues notices to Dr Reddy’s, Nestle Health Science and major e-commerce players including Amazon and Flipkart over potentially misleading health-related claims linked to protein supplement products.
According to multiple outlets, the regulator says some claims are presented in ways that could mislead consumers about the health benefits of the products. Reports also note the notices cover concerns around non-compliant advertising and misleading promotional content, including how health claims appear on product packaging and on online listings.
One outlet specifies the notice relates to “Celevida GLP+” on e-commerce platforms, while others describe the action more generally across the named companies and platforms. The notices indicate FSSAI is challenging the compliance of the marketing and claim statements used to promote the supplements, though the sources do not describe any final penalties or outcomes.
